Opioid use prior to elective surgery is strongly associated with persistent use following surgery: an analysis of 14 354 Medicare patients.


Journal

ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634

Informations de publication

Date de publication:
11 2019
Historique:
received: 27 06 2019
revised: 13 09 2019
accepted: 14 09 2019
pubmed: 23 10 2019
medline: 2 10 2020
entrez: 23 10 2019
Statut: ppublish

Résumé

Persistent opioid use following total joint replacement (TJR) surgery is common; however, the association between pre-surgical opioid use and surgery type has not been established. The objective of this study was to determine the association between pre-surgery opioid use and persistent post-surgery opioid use in TJR patients compared to other elective surgical patients. This is a retrospective cohort study, of univariate and multinomial logistic regression of linked, de-identified Medicare Benefits Schedule and Pharmaceutical Benefits Schedule data, adjusted for perioperative opioid use, age and sex. Oral morphine equivalents daily doses (OMEDD) were calculated and opioid use was categorized into three mutually exclusive categories for each observation window: low (0-5 OMEDD), moderate (5-10 OMEDD), high (10+ OMEDD). Persistent opioid use was defined as opioid use between 180 and 270 days after the date of surgery. Persistent opioid use was associated with older age, female gender and pre-surgery opioid use. There was no increased risk for persistent opioid use for TJR patients compared to other surgical patients. The intensity of pre-surgery opioid usage is strongly associated with persistent opioid use in all observed surgical patients. Our results suggest that many patients who use opioids prior to surgery will persist in their opioid use following surgery. No association was found between persistent opioid use and TJR surgery, but rather a risk reduction compared to other elective surgeries when associations with opioid use are controlled for. Primary care clinicians and surgeons should monitor the duration and dosage of perioperative opioid use.

Sections du résumé

BACKGROUND
Persistent opioid use following total joint replacement (TJR) surgery is common; however, the association between pre-surgical opioid use and surgery type has not been established. The objective of this study was to determine the association between pre-surgery opioid use and persistent post-surgery opioid use in TJR patients compared to other elective surgical patients.
METHODS
This is a retrospective cohort study, of univariate and multinomial logistic regression of linked, de-identified Medicare Benefits Schedule and Pharmaceutical Benefits Schedule data, adjusted for perioperative opioid use, age and sex. Oral morphine equivalents daily doses (OMEDD) were calculated and opioid use was categorized into three mutually exclusive categories for each observation window: low (0-5 OMEDD), moderate (5-10 OMEDD), high (10+ OMEDD). Persistent opioid use was defined as opioid use between 180 and 270 days after the date of surgery.
RESULTS
Persistent opioid use was associated with older age, female gender and pre-surgery opioid use. There was no increased risk for persistent opioid use for TJR patients compared to other surgical patients. The intensity of pre-surgery opioid usage is strongly associated with persistent opioid use in all observed surgical patients.
CONCLUSIONS
Our results suggest that many patients who use opioids prior to surgery will persist in their opioid use following surgery. No association was found between persistent opioid use and TJR surgery, but rather a risk reduction compared to other elective surgeries when associations with opioid use are controlled for. Primary care clinicians and surgeons should monitor the duration and dosage of perioperative opioid use.

Identifiants

pubmed: 31637832
doi: 10.1111/ans.15492
pmc: PMC6900005
doi:

Substances chimiques

Analgesics, Opioid 0
Morphine 76I7G6D29C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1410-1416

Subventions

Organisme : NHMRC Centre for Research Excellence in Total Joint Replacement OPtimising oUtcomes, equity, cost effectiveness and patient Selection (OPUS)
ID : APP1116325
Pays : International
Organisme : NHMRC Practitioner Fellowship
ID : APP1154203
Pays : International
Organisme : NHMRC Career Development Fellowship
ID : APP1122526
Pays : International
Organisme : Centre of Excellence in Population Ageing Research, Australian Research Council (CEPAR)
ID : CE170100005
Pays : International

Informations de copyright

© 2019 The Authors ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.

Références

Arthritis Rheum. 2006 Apr 15;55(2):241-7
pubmed: 16583414
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
World J Surg. 2019 Sep;43(9):2164-2174
pubmed: 31073685
J Bone Joint Surg Br. 2011 Mar;93(3):293-7
pubmed: 21357948
Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74
pubmed: 22563589
Aust N Z J Public Health. 2017 Feb;41(1):85-91
pubmed: 27624336
JAMA Intern Med. 2016 Sep 1;176(9):1286-93
pubmed: 27400458
Pain. 2016 Jun;157(6):1259-65
pubmed: 26871536
BMC Res Notes. 2015 Oct 05;8:536
pubmed: 26438323
Br J Clin Pharmacol. 2014 Nov;78(5):1159-66
pubmed: 24962372
J Clin Pharmacol. 2015 Jan;55(1):33-8
pubmed: 25052325
JAMA. 2017 Sep 19;318(11):1065-1067
pubmed: 28975295
Clin Med Insights Arthritis Musculoskelet Disord. 2012;5:89-94
pubmed: 23239930
Patient Prefer Adherence. 2016 Mar 09;10:283-90
pubmed: 27022250
Open Med. 2011;5(1):e13-22
pubmed: 22046214
Ann Rheum Dis. 2014 Jul;73(7):1323-30
pubmed: 24553908

Auteurs

Max Catchpool (M)

Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Department of Surgery, The University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia.

Josh Knight (J)

Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Jesse T Young (JT)

Justice Health Unit, Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Centre for Adolescent Health, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Philip Clarke (P)

Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Michael J Barrington (MJ)

Department of Anaesthesia and Acute Pain Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia.
Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.

Peter F M Choong (PFM)

Department of Surgery, The University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia.
Department of Orthopaedics, St Vincent's Hospital, Melbourne, Victoria, Australia.

Michelle M Dowsey (MM)

Department of Surgery, The University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia.
Department of Orthopaedics, St Vincent's Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH